GlobeNewswire

2018 International Cost Insight Product Cost Management Conference

Dela

Join the most Progressive Companies in the World to Learn How PCM Strategies & Technologies Improve Profitability & Accelerate Design to Delivery Time

CONCORD, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- aPriori, the leading provider of enterprise product cost management software solutions, announces today that the 6th annual Cost Insight International Product Cost Management conference will be held on June 11-13, 2018.

The venue for this year's event is Wentworth by the Sea in New Castle, New Hampshire, located approximately 1 hour from Boston Logan Airport by bus or car.  This event is open to both aPriori customers and representatives from any manufacturers that are interested in learning more about product cost management technology and best practices.

Visit the Cost Insight 2018 Event Website for complete information and register for this year's program.

Why Should You Attend Cost Insight 2018?

As pressure increases to deliver innovative and customized products to market faster, manufacturers are struggling to maintain product profits and accelerate design to delivery schedules.  At Cost Insight 2018, join attendees from leading product manufacturers around the world who will gather to share insights and discover new strategies and tactics in product design, sourcing and quoting to address this complex problem.

  • Learn from the Best
    • The International Cost Insight PCM Conference attracts the largest collection of companies and representatives from around the world who are using advanced product cost management strategies to help meet their business goals.
    • Hear case studies from some of the world's leading global manufacturers including Cisco, General Electric, and Whirlpool where they talk about results and lessons learned along their PCM journey. 
      • What are best practices for arming design engineers with early cost and DFM feedback to reduce churn
      • How companies are taking advantage of data in their digital transformation to generate cost and manufacturability insights to track new product development projects and to optimize designs
      • Where PCM solutions have been applied to change the way manufacturers collaborate with their suppliers
  • Practical Application Workshops
    • After General Sessions in the morning, attendees break into workshop tracks that align with either their role (design/engineering or sourcing/supply chain) or skill level.
    • An "Intro to PCM" track is provided on Day 1 for attendees who are planning to extend or implement product cost management in their product development, sourcing or quoting processes.  This track will include sessions on how to evaluate vendor partners, how to successfully develop a year 1 implementation plan and for folks who have a background in Cost Engineering, how to expand your reach by leveraging people in design/engineering to do early phase costing.
  • See the Latest PCM Technology Breakthroughs
    • Leaders of the aPriori product management team will talk about key breakthroughs and new capabilities that are going to be delivered in future releases of the product. 
    • New at this year's conference is an Advanced Technology Showcase - in an exhibition style setting, aPriori engineers will demonstrate the most exciting technology breakthroughs covering a variety of different use cases across aPriori's key industries of Aerospace & Defense, Automotive, Industrial Machinery and High Tech Electronic Equipment.

Who Should Attend?

Product Designers & Engineers If you have anything to do with designing or engineering a discrete manufactured product, and want to learn how to use cost and DFM data to optimize designs, and how to avoid subtle errors that increase manufacturing cost, and result in mind numbing ECOs.  you should join us at Cost Insight to learn how Design to Cost and Design for Manufacturability capabilities can help you innovate and eliminate  wasteful exercises.
Sourcing, Buyers, Supply Chain If you have anything to do with sourcing or buying engineered components or assemblies that become part of your finished product, and you're struggling to find new ways to squeeze cost out of these purchased parts..  you should join us at Cost Insight to learn how our should costing capabilities provide cost and manufacturing details the can help with vendor selection and negotiations and how our, bulk costing & analytics can help you quickly spot where you may be getting overcharged.
Design & Sourcing Team Management If you are managing a team that is responsible for product design or sourcing, and you are being asked by your senior executives to report on the forecast cost of the product throughout the design cycle.   you should join us at Cost Insight to learn how your team can leverage product cost estimation capabilities in aPriori to stay on track and design products to cost.
Cost Estimating Professionals If you're a professional cost estimator, working in either a big OEM or a mid-size supplier, and you simply can't keep up with the volume of costing requests.  you should join us at Cost Insight learn how aPriori can dramatically accelerate the process and help you provide DFM guidance to improve the value of customer's products

For More Information on Cost Insight 2018

For complete information and to register for the event, please visit the Cost Insight 2018 website

You can also follow the latest event updates on Twitter and LinkedIn.  Search for our event hashtag #CostInsight.

Interested individuals can also send an email to Rick Burke, aPriori Vice President of Marketing, at rburke@apriori.com or call +1-978-451-7675.

About aPriori
aPriori software and services generate hard-dollar product cost savings for discrete manufacturing and product innovation companies. Using aPriori's real-time product cost assessments, employees in engineering, sourcing and manufacturing make more-informed decisions that drive costs out of products pre- and post-production. With aPriori, manufacturers launch products at cost targets, maximize savings in re-work projects and avoid overpaying for sourced parts.  To learn more about aPriori and its product cost management solutions and services, visit www.apriori.com or call 1.978.371.2006. To see an overview demonstration of aPriori, click here.

aPriori on Twitter @aPriori_Inc.
aPriori on LinkedIn Product Costing Blog

aPriori and aPriori Technologies are registered trademarks of aPriori Technologies Inc. All other trademarks, registered trademarks or service marks belong to their respective holders.

CONTACT:
Rick Burke
Vice President, Marketing
rburke@apriori.com
978.451.7675




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: aPriori Technologies via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum